- Home
- FLGC vs PRPH Comparison
FLGC vs PRPH Comparison
Compare FLGC & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- PRPH
- Stock Information
- Founded
- FLGC 2019
- PRPH 1989
- Country
- FLGC United States
- PRPH United States
- Employees
- FLGC N/A
- PRPH N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- PRPH Health Care
- Exchange
- FLGC Nasdaq
- PRPH Nasdaq
- Market Cap
- FLGC 15.5M
- PRPH 15.5M
- IPO Year
- FLGC 2021
- PRPH 1997
- Fundamental
- Price
- FLGC $1.05
- PRPH $0.64
- Analyst Decision
- FLGC Strong Buy
- PRPH Strong Buy
- Analyst Count
- FLGC 4
- PRPH 1
- Target Price
- FLGC $5.67
- PRPH $11.00
- AVG Volume (30 Days)
- FLGC 956.1K
- PRPH 237.1K
- Earning Date
- FLGC 11-13-2024
- PRPH 11-13-2024
- Dividend Yield
- FLGC N/A
- PRPH N/A
- EPS Growth
- FLGC N/A
- PRPH N/A
- EPS
- FLGC N/A
- PRPH N/A
- Revenue
- FLGC $64,154,000.00
- PRPH $12,753,000.00
- Revenue This Year
- FLGC N/A
- PRPH $36.93
- Revenue Next Year
- FLGC $8.94
- PRPH $132.05
- P/E Ratio
- FLGC N/A
- PRPH N/A
- Revenue Growth
- FLGC N/A
- PRPH N/A
- 52 Week Low
- FLGC $0.75
- PRPH $0.61
- 52 Week High
- FLGC $2.93
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- FLGC 36.74
- PRPH 27.48
- Support Level
- FLGC $1.60
- PRPH $0.66
- Resistance Level
- FLGC $1.22
- PRPH $0.74
- Average True Range (ATR)
- FLGC 0.20
- PRPH 0.06
- MACD
- FLGC -0.08
- PRPH 0.04
- Stochastic Oscillator
- FLGC 7.89
- PRPH 10.71
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.